Product Overview

Soliriz 8mg Capsules 10s by Tabros are a medication containing the active ingredient Silodosin. These capsules are used to treat symptoms of an enlarged prostate, also known as benign prostatic hyperplasia (BPH).

Key Benefits

• Effectively reduces symptoms of BPH such as difficulty urinating, weak urine stream, and frequent urination
• Helps improve overall quality of life for individuals suffering from BPH
• Easy-to-take capsules for convenient dosing

How It Works

Silodosin, the active ingredient in Soliriz capsules, works by relaxing the muscles in the prostate and bladder. This relaxation helps to improve urine flow and reduce symptoms associated with BPH. By targeting the specific areas affected by BPH, Silodosin provides targeted relief for individuals experiencing urinary difficulties.

Directions for Use

1. Take one Soliriz 8mg capsule by mouth daily, with or without food.
2. Swallow the capsule whole with a full glass of water.
3. Do not crush, chew, or break the capsule.

Precautions

• Inform your healthcare provider about any other medications you are taking before starting Soliriz capsules.
• Do not exceed the recommended dosage of one capsule per day.
• If you experience any allergic reactions or severe side effects, seek medical help immediately.

Storage Instructions

Store Soliriz capsules at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not store in the bathroom or kitchen where moisture levels may be high.

Manufacturer Information

Soliriz 8mg Capsules 10s are manufactured by Tabros Pharmaceuticals. Tabros is a reputable pharmaceutical company known for producing high-quality medications to improve patient health and well-being.

Overall, Soliriz 8mg Capsules 10s by Tabros offer effective relief for individuals suffering from BPH symptoms. With the convenience of easy-to-take capsules and the targeted relief provided by Silodosin, this medication can help improve urinary function and quality of life for those affected by benign prostatic hyperplasia.